Movement Disorders Clinical Trial
Official title:
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducted at approximately 10 centers worldwide.
This is a post-approval registry which is required by of the approval under PMA P150038/S014 for the Exablate® Model 4000 (Exablate Neuro) Type 1.0 and Type 1.1 for unilateral pallidotomy in the treatment of idiopathic Parkinson's Disease with medication-refractory moderate to severe motor complications. Subjects participating in this registry will have received a unilateral pallidotomy using the commercially available Exablate Neuro. The following assessments will be collected at Baseline, 3, 6, and 12 months post Exablate procedure and annually thereafter for 5 years: Adverse Events (AEs) (does not apply to Baseline Visit) Medication usage MDS-UPDRS Unified Dyskinesia Rating Scale EQ-5D-5L WPAI-GH Clinician and Patient Global Impression of Change Patient Satisfaction Questionnaire ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05623644 -
Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
|
||
| Active, not recruiting |
NCT03548779 -
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
|
N/A | |
| Completed |
NCT03295786 -
Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT03722212 -
Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test
|
N/A | |
| Recruiting |
NCT05973929 -
Movement Disorders in Multiple Sclerosis Patients
|
||
| Terminated |
NCT02823158 -
Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM
|
N/A | |
| Enrolling by invitation |
NCT01210781 -
Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
|
||
| Enrolling by invitation |
NCT00355927 -
Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
|
N/A | |
| Completed |
NCT00037167 -
Effects of Exercise Poles on Older Adults During Exercise Walking
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04784494 -
MST for Parkinson's Disease
|
N/A | |
| Terminated |
NCT03270189 -
Effect of the Visual Information Change in Functional Dystonia
|
N/A | |
| Recruiting |
NCT04176692 -
The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements
|
||
| Recruiting |
NCT04061135 -
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
|
N/A | |
| Suspended |
NCT04912115 -
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
|
Phase 2 | |
| Completed |
NCT00500994 -
Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures
|
Early Phase 1 | |
| Completed |
NCT04536987 -
Robot Therapy for Rehabilitation of Hand Movement After Stroke
|
Phase 2 | |
| Recruiting |
NCT00001208 -
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
|
||
| Not yet recruiting |
NCT05560269 -
Verbal Cueing vs. Constraint-Led Approach for Teaching the Kettlebell Swing.
|
N/A | |
| Completed |
NCT02392078 -
Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
|
||
| Completed |
NCT00552474 -
Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
|
N/A |